Literature DB >> 22552940

Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection.

Alexandra Svensson1, Petra Tunbäck2, Inger Nordström1, Leonid Padyukov3, Kristina Eriksson1.   

Abstract

Lack of Toll-like receptor 3 (TLR3) functional activity predisposes children to human herpesvirus 1 (HSV-1) encephalitis. In this study, we have investigated whether there is any link between TLR3 and adult HSV-2 infection by studying genetic variations in TLR3. The frequency of four single-nucleotide polymorphisms (SNPs) in the TLR3 gene in 239 patients with genital HSV-2 infection and 162 healthy controls, as well as the impact of these variants on TLR3 gene-expression levels, were compared. Two SNPs in the TLR3 gene (rs13126816 and rs3775291) were associated with a reduced incidence of HSV-2 infection. The minor allelic variants at both rs13126816 and rs3775291 were more common among healthy HSV-2-seronegative subjects than among HSV-2-infected individuals. This was even more apparent in HSV-1-seronegative individuals. There was, however, no association between any of the four TLR3 SNPs and HSV-2 disease severity, as they were expressed at similar proportions in asymptomatic and symptomatic HSV-2-infected patients alike. Furthermore, when assessing TLR3 mRNA expression in a limited number of HSV-2-infected individuals, we found that individuals carrying the homozygous genotypes for the minor alleles had significantly higher levels of TLR3 mRNA expression in peripheral blood mononuclear cells in response to HSV-2 stimulation than individuals that were homozygous for the major allele variants. Taken together, these results suggest that genetic variations in TLR3 may affect the susceptibility to HSV-2 infection in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552940     DOI: 10.1099/vir.0.042572-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

Review 1.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

2.  Current status and prospects for development of an HSV vaccine.

Authors:  Christine Johnston; David M Koelle; Anna Wald
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

3.  Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virus.

Authors:  Feng Qian; Christopher R Bolen; Chunxia Jing; Xiaomei Wang; Wei Zheng; Hongyu Zhao; Erol Fikrig; R Douglas Bruce; Steven H Kleinstein; Ruth R Montgomery
Journal:  Clin Vaccine Immunol       Date:  2012-12-05

Review 4.  Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.

Authors:  Andrei E Medvedev
Journal:  J Interferon Cytokine Res       Date:  2013-05-15       Impact factor: 2.607

5.  HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships.

Authors:  Elaine L Bearer
Journal:  Future Virol       Date:  2012-09       Impact factor: 1.831

Review 6.  Genetic variants of innate immune receptors and infections after liver transplantation.

Authors:  Gemma Sanclemente; Asuncion Moreno; Miquel Navasa; Francisco Lozano; Carlos Cervera
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

7.  Toll like receptors: Sensors for herpes simplex virus infection.

Authors:  Balaji Govindan
Journal:  Indian J Sex Transm Dis AIDS       Date:  2014 Jul-Dec

8.  Polymorphisms of the Toll-Like Receptor-3 Gene in Autoimmune Adrenal Failure and Type 1 Diabetes in Polish Patients.

Authors:  Marta Fichna; Magdalena Żurawek; Piotr Fichna; Danuta Januszkiewicz-Lewandowska; Marek Ruchała; Jerzy Nowak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-08-30       Impact factor: 4.291

9.  Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation.

Authors:  Tao Peng; R Savanh Chanthaphavong; Sijie Sun; James A Trigilio; Khamsone Phasouk; Lei Jin; Erik D Layton; Alvason Z Li; Colin E Correnti; Willem De van der Schueren; Julio Vazquez; Diana R O'Day; Ian A Glass; David M Knipe; Anna Wald; Lawrence Corey; Jia Zhu
Journal:  J Exp Med       Date:  2017-06-29       Impact factor: 14.307

10.  Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children.

Authors:  Mirosława Studzińska; Agnieszka Jabłońska; Małgorzata Wiśniewska-Ligier; Dorota Nowakowska; Zuzanna Gaj; Zbigniew J Leśnikowski; Teresa Woźniakowska-Gęsicka; Jan Wilczyński; Edyta Paradowska
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.